Advanced search
Publication Cover
International Journal of Women's Health Volume 12, 2020 - Issue
Submit an article Journal homepage
305
Views
2
CrossRef citations to date
0
Altmetric
Article Commentary

Lactobacillus rhamnosus BMX 54 + Lactose, A Symbiotic Long-Lasting Vaginal Approach to Improve Women’s Health

Filippo BaldacciR&D Department, Laboratori Baldacci SpA, Pisa56124, Italy
,
Mara BaldacciR&D Department, Laboratori Baldacci SpA, Pisa56124, Italy
&
Marco BertiniR&D Department, Laboratori Baldacci SpA, Pisa56124, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1469-7825
ORCID Icon
Pages 1099-1104 | Published online: 19 Nov 2020

References

  • Wiesenfeld HC, Hiller SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol. 2002;100:453–456.
  • Ness RB, Kip KE, Hiller SL, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol. 2005;162:585–590. doi:10.1093/aje/kwi243
  • Spear GT, Glibert D, Landay AL, et al. Pyrosequencing of the genital microbiotas of HIV-sieronegative women reveals Lactobacillus iners as the predominant Lactobacillus species. Appl Environ Microbiol. 2011;77:378–381. doi:10.1128/AEM.00973-10
  • Bertini M. Bacterial vaginosis and sexually transmitted diseases: relationship and management. In: Serdaroglu S, Kutlubay Z, editors. Fundamentals of Sexually Transmitted Infections. INTECH Open; 2017:75.
  • Palma E, Bertini M. Vaginal microbiota and the pathobiosis path: its role in the evolution of the HPV cervical intraephitelial neoplasia and cancer. Eur J Gynaecol Oncol. 2019;40(4):534–537.
  • Albert DM, Doderlein G. A critical view to the bibliographies of two German Professor. Zentralbl Gynakol. 2006;128(2):56–59.
  • Miller EA, Beasley DE, Dunn RR, Archie EA. Lactobacilli dominance and vaginal pH: why is the human vaginal microbiome unique? Front Microbiol. 2016;7:1936.
  • GaGhazzewiFH A, Teser RF. Biotherapeutic agents and vaginal health. J Appl Microbiol. 2016;121(1):18–27. doi:10.1111/jam.13054
  • Balkus JE, Jakho W, Temmerman M, et al. The post-trial effect of oral periodic presuntive treatment for vginal infection on the incidence of bacterial vaginosis and Lactobacillus colonization. Sex Transm Infect. 2012;29:361–365.
  • Serok AC, Verstraelen H, Temmerman M, Botta GA. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst. Rev. 2009;(4):CD006289.
  • Lev-Sagie A, Glodman-Wohl D, Cohen Y. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat Med. 2019;25:1500–1504. doi:10.1038/s41591-019-0600-6
  • Parma M, Stella Vanni V, Bertini M, Candiani M. Probiotics in the prevention of recurrences of bacterial vaginosis. Altern Ther Health Med. 2014;20:52–57.
  • Recine N, Musciola A, Moreira E. The benefits of topical vaginal therapy with Lactobacillus casei sub-rhamnosus in preventing bacterial vaginosis relapses. In: Abstract Book of the X National IBAT Conference Naples; January 26 – 28, 2018.
  • Rossi A, Rossi T, Bertini M. The use of Lactobacillus rhamnosus in the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a population of 40 women treated for 24 months. Arch Gynecol Obstet. 2010;281:1065–1069. doi:10.1007/s00404-009-1287-6
  • Bertini M. Is Lactobacillus rhamnosus BMX 54 vaginal application a strategy to counteract bacterial vaginosis recurrences?: Proceedings of 18th World Congress on Controversis in Obstetrics, Gynecology and Infertility (COGI), WienOctober 24 – 27, 2013
  • Recine N, Palma E, Domenici L, et al. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis. Arch Gynecol Obstet. 2016;23(1):101–107. doi:10.1007/s00404-015-3810-2
  • Marcone V, Rocca B, Lichtner M, Calzolari E. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int J Obstet Gynecol. 2010;110:223–226. doi:10.1016/j.ijgo.2010.04.025
  • Stojanovic N, Plecas D, Plesinac S. Normal vaginal flora disorders and application of probiotics in pregnancy. Arch Gynecol Obstet. 2012;286(2):325–332. doi:10.1007/s00404-012-2293-7
  • Recine N, Palma E, Domenici L, Giorgini M, Pierangeli A, Benedetti Panici P Long-term probiotic implementation to re-create a balanced vaginal ecosystem: a promising boost against HPV. In: Abstract Book of International Scientific Conference on Probiotics and Prebiotics; June 21 – 23, 2016; Budapest Hungary.
  • Luzi G, Iazzetta E, Cecconi L, et al. Lactobacillus rhamnosus BMX 54 vaginal application usefulness as adjuvant therapy for preterm premature rupture of membranes (PPROM) in the second trimester of pregnancy. Int J Pediatr Neonatal Health. 2018;2(1):14–18.
  • Palma E, Recine N, Domenici L, Giorgini M, Pierangeli A, Panici PGB. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV infection. BMC Infect Dis. 2018;18(1):1–7.
  • Recine N, Domenici L, Bracchi C, Palma E, Benedetti Panici PG.How vaginal microbiota re-establishment can reduce sexually trasmitted diseases: an observational study on 2010 patients.Abstract Book of 2018 COGI Congress (London) OP 1 204.75

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.